Skip to main content
Fig. 2 | Archives of Public Health

Fig. 2

From: Evaluating anti-MRSA antibiotic stewardship with a focus on trends in consumption and resistance in a tertiary hospital in Alexandria, Egypt from 2019 to 2023

Fig. 2

Segmented Quarterly Trends in Hospital Consumption of Linezolid and Combined Vancomycin/Teicoplanin Before and After the COVID-19 Pandemic in a Tertiary Hospital in Alexandria, Egypt from 2019 to 2023. This figure presents a segmented regression analysis of quarterly hospital consumption trends of Linezolid (top panel) and combined Vancomycin/Teicoplanin (bottom panel) before and after the onset of the COVID-19 pandemic in a tertiary hospital in Alexandria, Egypt. Vertical lines indicate the start of COVID-19 case admissions. Abbreviations: DDD/1000PD, defined daily doses per 1000 patient-days; β, regression coefficient

Back to article page

Archives of Public Health

ISSN: 2049-3258